Laennec Placenta Therapy Solution
Pharmaceutical-grade hydrolyzed human placenta extract containing 300+ bioactive components including low molecular peptides (<5,000Da), 18 essential amino acids, and antioxidant complexes. Formulated under JP17 pharmacopeia standards with 98% bioavailability rate. Clinically validated for hepatic cell regeneration and dermal matrix restoration.
Therapeutic Advantages
✓ 83% ALT/AST normalization rate
✓ 5x glutathione synthesis boost
✓ 76% collagen density improvement
✓ ISO 9001/13485 certified
✓ 300+ active biomolecules
✓ 0.22μm sterile filtration
✓ pH-balanced formulation
✓ 15-year clinical application
Advanced Bioprocessing
Proprietary enzymatic hydrolysis technology preserves bioactive integrity through:
• Controlled 37°C incubation
• Multi-stage pathogen inactivation
• Molecular weight optimization (500-3,000Da)
• Trace element preservation (Zn, Se, Cu)
Pharmaceutical Specifications
➤ Sterile 2ml ampoules (Type I glass)
➤ 50 ampoules/box (GMP-certified)
➤ Storage: 2-8°C protected from light
➤ Lot-controlled stability testing
Clinical Protocol
1. Administer 2ml via subcutaneous/intramuscular injection
2. Standard course: 10-12 sessions/month
3. Compatible with vitamin complexes
4. Monitor hepatic biomarkers biweekly
5. Maintain cold chain during transportation
*Therapeutic outcomes may vary based on individual physiological conditions. Contraindicated for patients with autoimmune disorders or hormone-sensitive conditions. Must be administered by licensed medical professionals. Clinical data based on 2018-2022 multicenter trials (n=1,532).
Reviews
There are no reviews yet.